These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Hepatic expression of apolipoprotein E inhibits progression of atherosclerosis without reducing cholesterol levels in LDL receptor-deficient mice. Tsukamoto K; Tangirala RK; Chun S; Usher D; Puré E; Rader DJ Mol Ther; 2000 Feb; 1(2):189-94. PubMed ID: 10933930 [TBL] [Abstract][Full Text] [Related]
24. Genetic research in coronary heart disease. Motulsky AG Prog Clin Biol Res; 1984; 147():541-8. PubMed ID: 6330756 [TBL] [Abstract][Full Text] [Related]
25. DNA polymorphisms of the apolipoprotein genes--their use in the investigation of the genetic component of hyperlipidaemia and atherosclerosis. Humphries SE Atherosclerosis; 1988 Aug; 72(2-3):89-108. PubMed ID: 3063270 [TBL] [Abstract][Full Text] [Related]
26. [The genetic bases of the lipid metabolic disorders in atherosclerosis]. Tselĭko VI Tsitol Genet; 1996; 30(2):74-82. PubMed ID: 9281205 [TBL] [Abstract][Full Text] [Related]
29. [Lipoprotein receptors and atheromatosis]. Masana Marín L Med Clin (Barc); 1984 Jun; 83(3):119-21. PubMed ID: 6090823 [No Abstract] [Full Text] [Related]
30. [Progress in the study of lipoprotein metabolism and atherosclerosis: progress in the molecular genetic study of apolipoproteins and hyperlipidemia]. Itoh H; Mabuchi H; Takeda R Nihon Rinsho; 1988 Mar; 46(3):644-51. PubMed ID: 2900342 [No Abstract] [Full Text] [Related]
31. Short report on DNA marker at candidate locus. Solberg K; Rødningen OK; Tonstad S; Ose L; Berg K; Leren TP Clin Genet; 1993 Aug; 44(2):111. PubMed ID: 8275559 [No Abstract] [Full Text] [Related]
32. [Application of genetic principles to the causal assessment of atherosclerosis]. Miserez AR; Braun JR Ther Umsch; 1995 Dec; 52(12):835-43. PubMed ID: 8539656 [TBL] [Abstract][Full Text] [Related]
35. Triglyceride-rich lipoproteins and atherosclerosis: pathophysiological considerations. Bradley WA; Gianturco SH J Intern Med Suppl; 1994; 736():33-9. PubMed ID: 7986306 [TBL] [Abstract][Full Text] [Related]
36. [Lipid theory of atherosclerosis]. de Oya M Rev Clin Esp; 1988 Jan; 182(1):39-43. PubMed ID: 3287511 [No Abstract] [Full Text] [Related]
37. The Apo(a) gene: structure/function relationships and the possible link with thrombotic atheromatous disease. Rees A; Bishop A; Morgan R Br Med Bull; 1990 Oct; 46(4):873-90. PubMed ID: 2151625 [TBL] [Abstract][Full Text] [Related]
38. Interaction between the LDL-receptor gene bearing a novel mutation and a variant in the apolipoprotein A-II promoter: molecular study in a 1135-member familial hypercholesterolemia kindred. Takada D; Emi M; Ezura Y; Nobe Y; Kawamura K; Iino Y; Katayama Y; Xin Y; Wu LL; Larringa-Shum S; Stephenson SH; Hunt SC; Hopkins PN J Hum Genet; 2002; 47(12):656-64. PubMed ID: 12522687 [TBL] [Abstract][Full Text] [Related]
39. Pathobiology of familial hypercholesterolemic atherosclerosis. Aliev G; Castellani RJ; Petersen RB; Burnstock G; Perry G; Smith MA J Submicrosc Cytol Pathol; 2004; 36(3-4):225-40. PubMed ID: 15906597 [TBL] [Abstract][Full Text] [Related]
40. Murine models for study of lipoprotein metabolism and atherosclerosis. Witztum JL J Clin Invest; 1993 Aug; 92(2):536-7. PubMed ID: 8349795 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]